BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 20, 2017
View Archived Issues
Novel pocket-modified vancomycin analogues show potential as durable and potent antibiotics
Read More
Mutations in SCN9A gene linked to diabetic neuropathic pain
Read More
FDA accepts Rigel Pharmaceuticals' NDA for fostamatinib disodium
Read More
Axovant Sciences' nelotanserin obtains FDA fast track designation
Read More
Seattle Genetics halting phase III CASCADE study of vadastuximab talirine
Read More
Human umbilical cord mesenchymal stem cells evaluated in ischemic cardiomyopathy trial
Read More
EC approves biosimilar rituximab from Sandoz
Read More
Next generation diarylquinoline TBAJ-587 displays superior potency against tuberculosis
Read More
MedImmune introduces a novel anti-FcRII-a antibody
Read More
Engineered grafts show esophageal regeneration ability in a large animal model
Read More
Tessa Therapeutics enters alliance with Parker Institute for Cancer Immunotherapy
Read More
Cell Medica acquires Catapult Therapy TCR
Read More
Abide Therapeutics describes novel MGL/FAAH inhibitors
Read More
FDA approves Baxdela for ABSSSI
Read More
eFFECTOR Therapeutics identifies new MAP kinase signal-integrating kinase 1/2 inhibitors
Read More
Novel USP1 inhibitors identified at FORMA Therapeutics
Read More
Clovis Oncology presents positive topline data from phase III ARIEL3 study of rucaparib
Read More
ViiV Healthcare presents novel anti-HIV compounds
Read More
AstraZeneca, Cancer Research Technology patent GLS inhibitors
Read More
Narurapid and Narusus launched in Japan
Read More
Enzychem Lifesciences begins phase II trial of EC-18 in CIN
Read More
Novartis reports phase III data on RTH-258 in neovascular AMD
Read More